G1 Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in G1 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including G1 Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in G1 Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $586k | 192k | 3.05 |
| 2023-09-30 | $294k | 204k | 1.44 |
| 2023-06-30 | $302k | 121k | 2.49 |
| 2023-03-31 | $44k | 17k | 2.68 |
| 2022-09-30 | $1.1M | 90k | 12.49 |
| 2022-06-30 | $196k | 40k | 4.94 |
| 2021-09-30 | $352k | 26k | 13.43 |
| 2020-12-31 | $420k | 23k | 18.00 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management